Background Schizophrenia is one of the top 25 leading causes of disability worldwide in
2013. Despite its low prevalence, its health, social, and economic burden has been …

Background: The demand for clinically efficacious, safe, patient acceptable, and cost-
effective forms of treatment for mental illness is growing. Several studies have demonstrated …

Abstract Cost-of-illness (COI) studies often include the 'indirect'cost of lost production
resulting from disease, disability, and premature death, which is an important component of …

Background Cost-of-illness (COI) studies provide useful information on the economic burden
that schizophrenia imposes on a society. Objectives This study aims to give a general …

This paper aims to review longitudinal studies assessing the impact of cognition on function
in patients with schizophrenia. PubMed and Scholars Portal were searched using search …

Negative symptoms of schizophrenia are debilitating and chronic in nature, are difficult to
treat, and contribute to poor functional outcomes. Motivational deficits are a core negative …

Schizophrenia (SZ) is a debilitating brain disorder with a complex genetic architecture.
Genetic studies, especially recent genome-wide association studies (GWAS), have identified …

Aims Schizophrenia has the highest median societal cost per patient of all mental disorders.
This review summarizes the different costs/cost drivers (cost components) associated with …

Relative to the large investments in mobile health (mHealth) strategies for mental illnesses
such as anxiety and depression, the development of technology to facilitate illness self …

Background Schizophrenia imposes a substantial economic burden on society. This
updated systematic review aims to collate the latest societal cost of schizophrenia across …